Company has worked with GeminiBio for multiple years and designed in GeminiBio’s Yssel’s T-Cell Media with their novel allogeneic cell therapy workflow. The company experienced positive outcomes in the clinical development process and required an immediate and significant increase in demand for the critical media.
Company needed to secure supply for this media to confidently meet their manufacturing scale up. In addition, the customer also required incremental testing to ensure performance of media.
GeminiBio worked with the company to develop and validate the incremental product testing the customer required. GeminiBio then aligned with the customer on the annual forecast and identified the specific lot sizes required by month.
GeminiBio consistently manufacturers in accordance with the forecast and the company receives monthly batches on-time and in full. The company has requested some orders to be pulled in to meet their manufacturing schedule changes and GeminiBio consistently meets customer’s demand requests.